Clinical Report: Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

Overview

This clinical trial investigates the safety and efficacy of Adaptive Radiation Therapy (ART) in patients with locally advanced unresectable pancreatic cancer. The study aims to determine the safety and efficacy of ART in this patient population.

Background

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality, with limited treatment options for locally advanced unresectable cases. Current therapies often fail to provide adequate local control, necessitating innovative approaches like ART.

Data Highlights

No numerical data provided in the source material.

Key Findings

• ART aims to improve radiation targeting of aggressive cancer cells.
• The trial includes patients with histologically confirmed locally advanced unresectable PDAC.
• Participants will receive 5 radiation treatments over a 2-week period.
• Inclusion criteria require adequate organ function and ECOG performance status of 0-2.
• Exclusion criteria include prior radiation therapy and confirmed metastatic disease.

Clinical Implications

The findings from this trial will provide insights into the safety and effectiveness of ART in treating locally advanced pancreatic cancer.

Conclusion

The ongoing trial of ART for locally advanced unresectable pancreatic cancer may yield important data on its efficacy and safety.

Related Resources & Content

1. Josh Meyer, MD, FASTRO, ClinicalTrials.gov, 2023 -- Adaptive Radiation Therapy for the Treatment of Locally Advanced Unresectable Pancreatic Cancer
2. the asco post — Ablative Stereotactic Magnetic Resonance–Guided Adaptive Radiation Therapy for Pancreatic Ductal Adenocarcinoma
3. Updates in Surgery — Survival benefits of neoadjuvant chemotherapy in advanced pancreatic cancer with vascular resection: who benefits the most? A study on key predictive factors
4. the asco post — System to Improve Clinical Staging in Localized Pancreatic Cancer
5. the asco post — Metastasis-Directed Radiation Therapy Plus Chemotherapy in Oligometastatic Pancreatic Cancer
6. Radiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline
7. Ablative Stereotactic Magnetic Resonance–Guided Adaptive Radiation Therapy for Pancreatic Ductal Adenocarcinoma
8. https://www.oregon.gov/oha/HPA/DSI-HERC/MembersOnly/7.1d%20NCCN%202.2025%20pancreatic.pdf
9. Adaptive Radiation Therapy for the Treatment of Locally Advanced Unresectable Pancreatic Cancer - NCI
10. Study Details | NCT05764720 | Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach | ClinicalTrials.gov
11. JMIR Research Protocols - Stereotactic Adaptive Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer to Minimize Gastrointestinal Toxicity (ARTIA-Pancreas): Protocol for a Single-Arm Prospective Trial
12. Magnetic resonance-guided online adaptive stereotactic body radiotherapy for advanced inoperable pancreatic cancer: a prospective study | Radiation Oncology | Springer Nature Link
13. Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis of Prospective Trials - PubMed
14. Multi-Institutional Comparison of Ablative 5-Fraction Magnetic Resonance-Guided Online Adaptive Versus 15/25-Fraction Computed Tomography-Guided Moderately Hypofractionated Offline Adapted Radiation Therapy for Locally Advanced Pancreatic Cancer - PMC